Hemay808

· Tianjin Hemay Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hemay808, covering 2024-03-01 to 2024-03-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients [Phase 2]